BS Equity makes investments based on experience and attention to patents
The investment company Bagger-Sørensen Equity A/S is new, but it has 107 years of experience as part of the Bagger-Sørensen family business, who founded the golden eggs Dandy and Fertin Pharma.
BS Equity was established two years ago as an investment company with an industrial approach and looking for long-term investments. In a short time, 65 investments and 43 acquisitions have been made, and the goal is 7-10 primary investments in the longer term.
- We act as if we were employed in the instdustry when we want to create growth and develop a company. It's about seeing the full potential and making the company grow in the long run, and that's why we are supporters of long-term investments, says Søren Birn, CEO of BS Equity.
When we are in the phase where we are investigating an investment, we regularly brief Nicolai Kanved from Kanved Patent Consulting. He quickly gets an overview of the patent landscape in a technology - whether there are other patents and how strong a patent will be, says Søren Birn.
The investment company has 4 themes dealing with health, trends in consumer behavior and food, technology in production and sustainability. In addition, at least one of the UN's Global Goals must be included in a purchase or investment.
- Our history with pharmaceutical products means that we have extensive experience and knowledge in these areas. The more themes we can tick off, the better. One of our investments is a company that develops equipment for replacement of traditional pasteurization, and here we can tick all themes, but it's not like that every time, says Søren Birn.
He is a former CEO of Gumlink A/S and Fertin Pharma A/S, and he is very much aware of the daily challenges in the industry seen from the executive chair, which increases BS Equity's competences in working with them.
- We bring experience from managing and we are aware of the day-to-day operations. You cannot manage a company by using an Excel sheet, as it is people and processes that must work together. Everything does not always go smoothly, but if you get the right people to play together with systems and have a clear strategy, it is a good starting point, says Søren Birn.
When BS Equity invests, it is with a close relation to the new company. For Søren Birn, it's all about making knowledge and networks available to the new company, showing interest and not just stopping by 4 times a year for board meetings.
When investing and buying companies, BS Equity can rely on 107 years of experience in innovation, strategy and management, but when it comes to patents, the company needs advice.
- In some cases, we look closely at whether there are inventions and how they can possibly be protected with patents. The product may be smart, but if it can be easily copied, it may not be a good investment. It is also important with differentiation in the market and a suitable risk profile. When we are in the phase where we are investigating an investment, we regularly brief Nicolai Kanved from Kanved Patent Consulting. He quickly gets an overview of the patent landscape in a technology – whether there are other patents and how strong a patent will be, says Søren Birn.
BS Equity use the expertise of advisers in connection with applications for new patents, but just as often when it comes to a company's ability to act without infringing other patent rights, also called "freedom-to-operate". This is where the risk profile with IPR is assessed.
- We need to know the extent to which we are free to act commercially in relation to existing patents from competing companies. We will be presented with some scenarios in relation to patent legislation and how to challenge a patent. If it is assessed that there is no "freedom-to-operate", it is of course a challenge to proceed with the investment, says Søren Birn.
BS Equity has been given advice from Kanved Patent Consulting in connection with challenging a patent on the American market, where, after further investigation, it turned out that there were some opportunities to design around the patent, which led to a successful investment.
- We have had a good collaboration with Nicolai Kanved over several years. The advantage is that we call him directly, and he is quick to get an overview. Nicolai is not only competent when it comes to patent law, but he is also strong when it comes to the technical context – he understands the chemistry, biology and technology of the matter, emphasizes Søren Birn.
Kanved Patent Consulting works for BS Equity A/S with:
Based on more than 100 years of experience in entrepreneurship and building well-known and well-run companies, Bagger-Sørensen Equity A/S invests in small and medium-sized companies with growth potential.
They invest in companies where they believe that their active ownership and capital can support the individual company's ability to pursue ambitious goals.
They develop companies responsibly and with a balanced attention to societal interests, customers, employees, partners and owners.
They are always open for a discussion of possible investments. Whether the decision to sell or look for a partner has already been made, or it is an early consideration, they want to engage in dialogue.
Share:
Share:
Kanved Patent Consulting is a full-service patent agency, specialized in technical, legal and strategic counseling in the field of patents and industrial designs. We have the capacity, experience and knowledge to advise in the field of intangible assets, from protection with patents and utility models to copyright, licensing and protection of trade secrets. Together, we convert your ideas into successful business propositions.
Kanved Patent Consulting ApS
Advice House
Lysholt Allé 10
7100 Vejle
Denmark (DK)
Tel: +45 70 70 70 28
Email: info@kanved.com
Vat. No. 38 98 17 65
